Warren G. Magnuson Clinical Center (CC)

62 Protocols (60 Active Accrual of new subjects, 2 Follow-up of previously enrolled subjects)

 05-CC-0003:

A Pilot Study to Detect the Effect of Sildenafil Citrate on Cerebral Blood Perfusion in Multiple Sclerosis Patients by Perfusion MRI

 04-CC-0237:

The Effects of Respiratory Motion on CT Based Attenuation Correction of Positron Emission Tomography Data: Liver and Heart Studies

 04-CC-0194:

Utility of Isoproterenol Challenge Test to Detect Disease in Patients with Incomplete Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy

 04-CC-0178:

The Treatment of Deep Vein Thrombosis of the Lower Extremities with "Low-Dose" Alteplase: a Pilot Study

 04-CC-0130:

The Effect of a Systemic Oral Care Program on Reducing Exposure to Oropharyngeal Pathogens in Critically III Patients

 04-CC-0119:

Biomarkers and Protein Mass Expression Profiles in Bronchoalveolar Lavage from Patients with Lung Infiltrates

 04-CC-0118:

Assessment of the Natural History and Peptide Immunization-Induced Immunological Response in Patients at High Risk for Recurrence of Anaplastic Nasopharyngeal Cancer

 04-CC-0109:

Comprehensive Prostate MRI for the Evaluation of Prostate Cancer at 3:OT: A Pilot Study

 04-CC-0085:

The Effect of Lopinavir/Ritonavir on Endothelial Function in Normal Volunteers

 04-CC-0070:

Exploring Patient-Provider Trust Among Individuals with End-Stage Renal Disease

 04-CC-0046:

Citrate Effects and Bone Density Studies in Long-Term Apheresis Donors

 04-CC-0040:

Prednisolone Pharmacokinetics in the Presence and Absence of Ritonavir after Oral Prednisolone Administration to Healthy Volunteers

 04-CC-0032:

Atorvastatin Therapy To Improve Endothelial Function in Sickle Cell Disease

 04-CC-0007:

Comprehensive Epitope Mapping of the Epstein-Barr Virus Latent Membrane Protein-2 in Ethnically Diverse Populations

 03-CC-0306:

A Phase I/II Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of Intravenous Immunoglobulin G (Omr-IgG-am) Containing High Anti-West Nile Virus Antibody Titers in Patients with, or at High Risk for Progression to West Nile Virus (WN

 03-CC-0305:

Investigation of the Natural History of West Nile Infection in Patients with, or at Risk for Progression to West Nile Virus Encephalitis and/or Myelitis

 03-CC-0301:

Health Beliefs and Health Behavior Practices among Minorities with Rheumatic Diseases

 03-CC-0258:

Classification of Fetal Breathing Patterns in the Maturing Upper Airway: Spectral Waveform Analysis of Amniotic Fluid Flow Dynamics in Normal Development, Polyhydramnios, and Oligohydramnios

 03-CC-0247:

Using MR Perfusion Imaging and Hypercapnia to Study Angiogenesis in Multiple Sclerosis Patients

 03-CC-0166:

Respiratory Cycle Biofeedback During CT Guided Procedures

 03-CC-0127:

Evaluation of Potential Synergy of Combining Hydroxyurea with Nitric Oxide Donors on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia

 03-CC-0113:

Treatment of Jugular, Subclavian, and/or Innominate Vein Thrombosis with Low Dose Recombinant Tissue Plasminogen Activator plus Anticoagulation

 03-CC-0091:

Global Initiative to Characterize Differences in Antiretroviral Pharmacokinetics in HIV-Infected Populations

 03-CC-0060:

Virtual Functional Anatomy (VFA)

 03-CC-0052:

Influence of MDR1 Genotype on Indinavir and Saquinavir Pharmacokinetics in Healthy Volunteers

 03-CC-0028:

Exploring the Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates

 02-CC-0289:

Double-Blind, Vehicle-Controlled Study to Evaluate Apoptosis in Basal Cell Carcinoma Treated with Aldara™ (Trademark) (Imiquimod) Cream, 5% Applied Once or Twice a Day

 02-CC-0266:

Acute Cardiac Allograft Cellular Rejection and Cardiac Allograft Vasculopathy: Identification of Diagnostic Biomarkers and Target Pathways for Preventive Therapy

 02-CC-0245:

The Use of Microdialysis/Acupuncture Needle to Assess the Local Tissue Milieu in Active and Latent Myofascial Trigger Points in the Upper Trapezius Muscle in Individuals With and Without Neck Pain

 02-CC-0244:

Radiofrequency Ablation of Painful Soft Tissue Neoplasms

 02-CC-0208:

Endothelial Dysfunction as a Risk Factor in HIV Study

 02-CC-0203:

Heparin vs. Lepirudin Flushes in Preventing Withdrawal Occlusion of Tunneled, Open-ended Venous Access Devices: A Blinded, Randomized, Clinical Trial

 02-CC-0168:

Pharmacokinetics of Valganciclovir in Kidney and Kidney/Pancreas Transplant Recipients

 02-CC-0146:

A Pilot Study Evaluating the Assessment Process for Constipation in Pediatric Oncology Patients who are Receiving Vinca Alkaloids and/or Narcotics

 02-CC-0053:

A Randomized Study Evaluating the Process and Outcomes of the Pain and Palliative Care Team Intervention

 02-CC-0045:

A Prospective (Cohort) Study to Identify Factors Affecting Morbidity Following the Diagnosis and Treatment of Patients with Breast Cancer: A Multi-Institutional Study Between NIH/RMD and NNMC/BCC

 02-CC-0044:

Morbidity Following the Diagnosis and Treatment of Patients with Breast Cancer: A Multi-Institutional Study Between the National Institutes of Health (NIH) Rehabilitation Medicine Department (RMD) and the National Naval Medical Center (NNMC) Breast Care

 01-CC-0237:

Toward a Theory of Technology Dependency and Health Related Quality of Life (HRQL): A Test of a Model in Patients with an Implantable Cardioverter Defibrillator

 01-CC-0231:

A Prospective Study of Transfusion-Transmitted Infections

 01-CC-0135:

Effect of Task on Oral Pressure Dynamics During Swallowing

 01-CC-0077:

Platelet Dysfunction in Patients Treated with SSRI Versus Non-SSRI Antidepressants

 01-CC-0045:

Studies of Phlebotomy Therapy in Hereditary Hemochromatosis

 01-CC-0044:

Task-Induced Physiological and Biomechanical Changes of the In Vivo Human Tongue

 00-CC-0165:

Filgrastim-Mobilized Peripheral Blood Stem Cells for Primary Allogeneic Transplantation Using Unrelated Donors Participating in the National Marrow Donor Program (NMDP)

 00-CC-0096:

Investigations in Discourse Processes

 99-CC-0168:

Collection and Distribution of Blood Components from Healthy Donors for In Vitro Research Use

 99-CC-0163:

Functional and Metabolic Imaging Using Magnetic Resonance at 3.0 and 1.5 Tesla

 99-CC-0061:

Contrast Enhanced Resonance Angiography (MRA) in the Diagnosis of Atherosclerotic Disease: A Pilot Technical Development Study

 98-CC-0090:

Evaluation of Hematologic Patients - Training Protocol

 98-CC-0067:

Treatment of Acute Deep Vein Thrombosis of the Lower Extremity with Intraclot, Pulse-Sprayed Recombinant Tissue Plasminogen Activator, Plus Heparin and Warfarin: A Pilot Study

 98-CC-0066:

Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan

 98-CC-0019:

Normal Volunteer Scanning on MR

 95-CC-0123:

Evaluation of Healthy Volunteer Marrow Donors Participating in the National Marrow Donor Program (NMDP)

 94-CC-0130:

Rehabilitation Medicine Screening Protocol

 92-CC-0141:

The Cardiopulmonary Effects of Endotoxin in Normal Human Volunteers

 91-CC-0117:

Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection in a Blood Donor Population

 90-CC-0168:

A Rigid Body Data Base on Human Movement

 87-CC-0160:

Comparison of Ultrasound and Videofluoroscopic Imaging Techniques in Diagnosing Oropharyngeal Dysphagia in Neurologically Impaired Subjects

 87-CC-0091:

Nuclear Magnetic Resonance Imaging/Spectroscopy at 1.5 and 3.0 Tesla

 79-CC-0101:

Exploration of the Diagnostic Capabilities of Ultrasound of the Oropharynx and Larynx

 03-CC-0046:

A Study of Daclizumab in Chronic Immune Thrombocytopenia (ITP)

 99-CC-0013:

Sonographic Evaluation of the Effects of Raloxifene on the Uterus and Ovaries in Premenopausal Patients at High Risk for Developing Breast Cancer

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home

Warren Grant Magnuson Clinical Center (CC)
National Institutes of Health (NIH)
Bethesda, Maryland 20892. Last update: 10/14/2004